Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes Post date 28 June 2022 ← NHS should publish exit interviews to allow doctors to compare conditions, meeting declares → No excuse for trusts not to offer pension recycling, BMA says